T44.0

Clinical Causes: Accidental overdose of anticholinesterase medications Intentional overdose in cases of self-harm or suicide attempts Incorrect dosing during medication administration Misuse of medications due to misdiagnosis or misunderstanding of dosage instructions Delayed clearance or metabolism of the medication due to liver or kidney impairment

Key Symptoms: Muscle weakness or paralysis Increased salivation and sweating Gastrointestinal disturbances such as nausea, vomiting, and diarrhea Bradycardia (slow heart rate) Difficulty breathing or respiratory distress Cramps and fasciculations (muscle twitching) Blurred vision and drooling Confusion or altered mental status

Diagnosis Path: Diagnosis involves a comprehensive medical assessment, including a detailed history of medication intake. Laboratory tests such as blood cholinesterase activity levels can confirm poisoning. Additional evaluations may include neurological examinations, electrocardiograms, and imaging studies if necessary to assess complication severity and rule out other causes of symptoms.

Treatment Protocols: Treatment strategies aim to remove or neutralize the toxin, support vital functions, and manage symptoms. Key interventions include: - Administration of atropine, which blocks parasympathetic effects caused by excessive acetylcholine - Use of pralidoxime (2-PAM) to regenerate cholinesterase activity and counteract the effects - Supportive care such as oxygen therapy and mechanical ventilation if respiratory muscles are affected - Gastric decontamination methods like activated charcoal, if appropriate and administered promptly - Continuous monitoring of cardiac and respiratory status Early medical intervention is crucial to prevent severe complications or death. Follow-up care may involve neurological assessments and medication adjustments to prevent recurrence.